T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Entergy
ETR
$49.7B
| $640M | 0.13% |
18,166,292
-580,762
| -3% | -$21.8M |
|
|
RDS.A
177
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $638M | 0.13% |
11,811,898
-3,782,463
| -24% | -$217M |
|
178
Franco-Nevada
FNV
$46.4B
| $638M | 0.13% |
13,389,380
-352,290
| -3% | -$17.9M |
|
179
Trip.com Group
TCOM
$29.1B
| $632M | 0.13% |
17,393,312
+608,852
| +4% | +$21.3M |
|
180
MSCI
MSCI
$40.8B
| $628M | 0.13% |
10,201,848
+72,870
| +0.7% | +$4.52M |
|
181
Fidelity National Information Services
FIS
$22.1B
| $627M | 0.13% |
10,147,419
-3,267,704
| -24% | -$209M |
|
|
STI
182
DELISTED
SunTrust Banks, Inc.
STI
| $626M | 0.13% |
14,557,625
+74,180
| +0.5% | +$3.15M |
|
183
Acuity Brands
AYI
$10.7B
| $625M | 0.13% |
3,473,670
-404,684
| -10% | -$71M |
|
184
Archer Daniels Midland
ADM
$38.8B
| $625M | 0.13% |
12,961,422
-131,200
| -1% | -$6.62M |
|
185
Teleflex
TFX
$5.91B
| $624M | 0.13% |
4,610,400
+38,590
| +0.8% | +$4.9M |
|
|
HCC
186
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $620M | 0.13% |
8,065,270
-68,760
| -0.8% | -$4.28M |
|
187
Duke Energy
DUK
$96.1B
| $612M | 0.13% |
8,663,114
-215,119
| -2% | -$16.3M |
|
188
Loews
L
$23.1B
| $605M | 0.12% |
15,710,488
+3,426,205
| +28% | +$139M |
|
189
Zillow
ZG
$7.71B
| $598M | 0.12% |
20,670,384
+7,316,949
| +55% | +$228M |
|
190
CNX Resources
CNX
$5.35B
| $587M | 0.12% |
32,426,627
+1,540,863
| +5% | +$36.9M |
|
|
SHPG
191
DELISTED
Shire pic
SHPG
| $584M | 0.12% |
2,419,585
+941,493
| +64% | +$233M |
|
192
Western Union
WU
$2.2B
| $584M | 0.12% |
28,714,582
-5,001,668
| -15% | -$106M |
|
|
SIRO
193
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $583M | 0.12% |
5,805,152
-120,574
| -2% | -$11.6M |
|
194
JB Hunt Transport Services
JBHT
$24.9B
| $580M | 0.12% |
7,070,280
-4,698,710
| -40% | -$408M |
|
195
JD.com
JD
$43.1B
| $571M | 0.12% |
16,757,304
+16,718,331
| +42,897% | +$568M |
|
196
Xcel Energy
XEL
$48.5B
| $571M | 0.12% |
17,752,771
+7,905,389
| +80% | +$266M |
|
197
Costco
COST
$419B
| $571M | 0.12% |
4,227,919
-1,367,100
| -24% | -$197M |
|
|
AGN.PRA
198
DELISTED
Allergan plc
AGN.PRA
| $570M | 0.12% |
+548,825
| New | +$575M |
|
199
AvalonBay Communities
AVB
$26B
| $569M | 0.12% |
3,557,320
+65,809
| +2% | +$11M |
|
200
BorgWarner
BWA
$14.2B
| $561M | 0.12% |
11,204,484
+299,605
| +3% | +$16M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.